{"id":10983,"date":"2025-11-17T14:43:34","date_gmt":"2025-11-17T20:43:34","guid":{"rendered":"https:\/\/ibio.org\/?p=10983"},"modified":"2025-11-17T14:43:34","modified_gmt":"2025-11-17T20:43:34","slug":"this-months-gbg-report-non-dilutive-funding-opportunities-november-2025","status":"publish","type":"post","link":"https:\/\/ibio.org\/this-months-gbg-report-non-dilutive-funding-opportunities-november-2025\/","title":{"rendered":"This Month\u2019s GBG Report: Non-Dilutive Funding Opportunities (November 2025)"},"content":{"rendered":"<p class=\"p1\"><span class=\"s2\">Even with Washington hitting the pause button during the federal shutdown, this month\u2019s GBG Report still surfaced <\/span><span class=\"s1\">78 new non-dilutive funding opportunities<\/span><span class=\"s2\">, notices of special interest, and RFIs across the life sciences landscape. That\u2019s a slimmer number than usual \u2014 no surprise given the slowdown \u2014 but the quality and strategic relevance of these opportunities remain strong.<\/span><\/p>\n<p class=\"p1\"><span class=\"s2\">As part of <\/span><span class=\"s1\">iBIO\u2019s partnership with G2G Consulting<\/span><span class=\"s2\">, our members receive exclusive access to this report each month, along with a private consultation option during the GBG webinar. You can find the <\/span><span class=\"s1\">full November GBG Report on the iBIO website<\/span><span class=\"s2\">.<\/span><\/p>\n<p class=\"p1\"><span class=\"s1\">Highlights From This Month\u2019s Report<\/span><\/p>\n<p class=\"p1\"><span class=\"s2\">BARDA leads several near-term deadlines, including the <\/span><span class=\"s1\">Agnostic Diagnostics mNGS solicitation<\/span><span class=\"s2\">(11\/20), the <\/span><span class=\"s1\">Rapid Antibody Production RFI<\/span><span class=\"s2\"> (12\/4), and the <\/span><span class=\"s1\">BioTools Innovator Program<\/span><span class=\"s2\"> for early-stage technology developers (12\/1). Additional BARDA opportunities extend into early 2026, such as <\/span><span class=\"s1\">ReadyDetect<\/span><span class=\"s2\">, the <\/span><span class=\"s1\">Paratus Digital Health Accelerator<\/span><span class=\"s2\">, and funding for <\/span><span class=\"s1\">wearable biosensor technologies<\/span><span class=\"s2\"> (1\/15). Other notable openings include <\/span><span class=\"s1\">PCORI\u2019s FY26 Cycle 1 PFA<\/span><span class=\"s2\"> supporting retrospective comparative-effectiveness studies (LOI due 1\/6) and the <\/span><span class=\"s1\">DoD SBIR Release 12<\/span><span class=\"s2\">, which encompasses topics ranging from shelf-stable nucleic acid synthesis reagents to CBRN sensing platforms (12\/10). The report also covers new opportunities in women\u2019s health, pediatric innovation, infectious disease, biomanufacturing, and small-business development.<\/span><\/p>\n<p class=\"p1\"><span class=\"s1\">\ud83d\udcc4 <\/span><a href=\"https:\/\/ibio.org\/wp-content\/uploads\/G2Gs-GBG-Report-for-iBIO-11-12-25.pdf\"><span class=\"s2\">Full Report<\/span><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Even with Washington hitting the pause button during the federal shutdown, this month\u2019s GBG Report still surfaced 78 new non-dilutive funding opportunities, notices of special interest, and RFIs across the life sciences landscape. That\u2019s a slimmer number than usual \u2014 no surprise given the slowdown \u2014 but the quality and strategic relevance of these opportunities [&hellip;]<\/p>\n","protected":false},"author":12,"featured_media":10618,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[143],"tags":[553,212,224],"class_list":["post-10983","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ibio-news","tag-funding","tag-grants","tag-non-dilutive-funding"],"_links":{"self":[{"href":"https:\/\/ibio.org\/wp-json\/wp\/v2\/posts\/10983","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ibio.org\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ibio.org\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ibio.org\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/ibio.org\/wp-json\/wp\/v2\/comments?post=10983"}],"version-history":[{"count":1,"href":"https:\/\/ibio.org\/wp-json\/wp\/v2\/posts\/10983\/revisions"}],"predecessor-version":[{"id":10984,"href":"https:\/\/ibio.org\/wp-json\/wp\/v2\/posts\/10983\/revisions\/10984"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ibio.org\/wp-json\/wp\/v2\/media\/10618"}],"wp:attachment":[{"href":"https:\/\/ibio.org\/wp-json\/wp\/v2\/media?parent=10983"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ibio.org\/wp-json\/wp\/v2\/categories?post=10983"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ibio.org\/wp-json\/wp\/v2\/tags?post=10983"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}